Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer

le Matsubara, Nobuaki, Mukai, Hirofumi, Naito, Yoichi, Nezu, Masahiko, Itoh, Kuniaki
Foilsithe 2013

Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance st...

le Suzuki, Kazuhiro, Matsubara, Nobuaki, Kazama, Hirotaka, Seto, Takeshi, Tsukube, Shoko, Matsuyama, Hideyasu
Foilsithe in Jpn J Clin Oncol (2019)

Cisplatin and S‐1 for urachal carcinoma: A single‐institution case series

le Urasaki, Tetsuya, Naito, Yoichi, Matsubara, Nobuaki, Sasaki, Masaoki, Kogawa, Takahiro, Hosono, Ako
Foilsithe in IJU Case Rep (2019)

Real-world efficacy and safety of two doses of cabazitaxel (20 or 25 mg/m(2)) in patients with castration-resistant prostate cancer: results of a Japanese post-marketing surveillan...

le Matsuyama, Hideyasu, Matsubara, Nobuaki, Kazama, Hirotaka, Seto, Takeshi, Tsukube, Shoko, Suzuki, Kazuhiro
Foilsithe in BMC Cancer (2020)

Phase-1 study of abiraterone acetate in chemotherapy-naïve Japanese patients with castration-resistant prostate cancer

le Matsubara, Nobuaki, Uemura, Hiroji, Fukui, Iwao, Niwakawa, Masashi, Yamaguchi, Akito, Iizuka, Koho, Akaza, Hideyuki
Foilsithe in Cancer Sci (2014)

Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases

le Uemura, Hiroji, Uemura, Hirotsugu, Matsubara, Nobuaki, Kinuya, Seigo, Hosono, Makoto, Yajima, Yoko, Doi, Toshihiko
Foilsithe in Int J Clin Oncol (2017)

Baseline neutrophil-to-lymphocyte ratio predicts the prognosis of castration-resistant prostate cancer treated with abiraterone acetate

le Yasui, Masato, Hasegawa, Yoriko, Kawahara, Takashi, Kumano, Yohei, Miyoshi, Yasuhide, Matsubara, Nobuaki, Uemura, Hiroji
Foilsithe in Mol Clin Oncol (2018)

Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide

le Kumano, Yohei, Hasegawa, Yoriko, Kawahara, Takashi, Yasui, Masato, Miyoshi, Yasuhide, Matsubara, Nobuaki, Uemura, Hiroji
Foilsithe in Biomed Res Int (2019)

Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors

le Doi, Toshihiko, Matsubara, Nobuaki, Kawai, Akira, Naka, Norifumi, Takahashi, Shunji, Uemura, Hiroji, Yamamoto, Noboru
Foilsithe in Invest New Drugs (2019)

Shared decision making, physicians’ explanations, and treatment satisfaction: a cross-sectional survey of prostate cancer patients

le Nakayama, Kazuhiro, Osaka, Wakako, Matsubara, Nobuaki, Takeuchi, Tsutomu, Toyoda, Mayumi, Ohtake, Noriyuki, Uemura, Hiroji
Foilsithe in BMC Med Inform Decis Mak (2020)

Phase 1 combination study of Eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer

le Mukai, Hirofumi, Saeki, Toshiaki, Shimada, Ken, Naito, Yoichi, Matsubara, Nobuaki, Nakanishi, Tadashi, Obaishi, Hiroshi, Namiki, Masayuki, Sasaki, Yasutsuna
Foilsithe in Invest New Drugs (2014)

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a r...

le Fukasawa, Satoshi, Suzuki, Hiroyoshi, Kawaguchi, Kazushiro, Noguchi, Hidehisa, Enjo, Kentaro, Tran, Namphuong, Todd, Mary, Fizazi, Karim, Matsubara, Nobuaki
Foilsithe in Jpn J Clin Oncol (2018)

Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer

le Sasaki, Akinori, Harano, Kenichi, Kogawa, Takahiro, Matsubara, Nobuaki, Naito, Yoichi, Hosono, Ako, Mukai, Hirofumi, Yoshino, Takayuki, Mukohara, Toru
Foilsithe in Case Rep Oncol Med (2020)

Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumors

le Shitara, Kohei, Yamazaki, Kentaro, Tsushima, Takahiro, Naito, Tateaki, Matsubara, Nobuaki, Watanabe, Morihiro, Sarholz, Barbara, Johne, Andreas, Doi, Toshihiko
Foilsithe in Jpn J Clin Oncol (2020)

Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors

le Doi, Toshihiko, Fujiwara, Yutaka, Matsubara, Nobuaki, Tomomatsu, Junichi, Iwasa, Satoru, Tanaka, Akari, Endo-Tsukude, Chihiro, Nakagawa, Shintaro, Takahashi, Shunji
Foilsithe in Cancer Chemother Pharmacol (2019)

A Phase 2 Trial of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer and without Prior Chemotherapy (JPN-201 Study)

le Matsubara, Nobuaki, Uemura, Hirotsugu, Satoh, Takefumi, Suzuki, Hiroyoshi, Nishiyama, Tsutomu, Uemura, Hiroji, Hashine, Katsuyoshi, Imanaka, Keiichiro, Ozono, Seiichiro, Akaza, Hideyuki
Foilsithe in Jpn J Clin Oncol (2014)

Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer

le Matsubara, Nobuaki, Mukai, Hirofumi, Hosono, Ako, Onomura, Mai, Sasaki, Masaoki, Yajima, Yoko, Hashizume, Kensei, Yasuda, Masanobu, Uemura, Miho, Zurth, Christian
Foilsithe in Cancer Chemother Pharmacol (2017)

Erratum to: Phase 1 study of darolutamide (ODM-201), a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer

le Matsubara, Nobuaki, Mukai, Hirofumi, Hosono, Ako, Onomura, Mai, Sasaki, Masaoki, Yajima, Yoko, Hashizume, Kensei, Yasuda, Masanobu, Uemura, Miho, Zurth, Christian
Foilsithe in Cancer Chemother Pharmacol (2017)

Neo-Bioscore in Guiding Post-surgical Therapy in Patients With Triple-negative Breast Cancer Who Received Neoadjuvant Chemotherapy

le HASEGAWA, YORIKO, MATSUBARA, NOBUAKI, KOGAWA, TAKAHIRO, NAITO, YOICHI, HARANO, KENICHI, HOSONO, AKO, ONISHI, TATSUYA, HOJO, TAKASHI, SHIMOKAWA, MOTOTSUGU, MUKOHARA, TORU
Foilsithe in In Vivo (2021)

Abiraterone acetate after progression with enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: a multi-center retrospective analysis

le Yamada, Yoko, Matsubara, Nobuaki, Tabata, Ken-ichi, Satoh, Takefumi, Kamiya, Naoto, Suzuki, Hiroyoshi, Kawahara, Takashi, Uemura, Hiroji, Yano, Akihiro, Kawakami, Satoru
Foilsithe in BMC Res Notes (2016)